Invention Grant
- Patent Title: Modulators of stimulator of interferon genes (STING)
-
Application No.: US16652221Application Date: 2018-10-04
-
Publication No.: US11377440B2Publication Date: 2022-07-05
- Inventor: David T. Fosbenner , Todd L. Graybill , Jianxing Kang , Bryan W. King , Yunfeng Lan , Lara Kathryn Leister , Mukesh K. Mahajan , John F. Mehlmann , Angel I. Morales-Ramos , George Scott Pesiridis , Joshi M. Ramanjulu , Joseph J. Romano , Stuart Paul Romeril , Mark J. Schulz , Huiqiang Zhou , Junya Qu
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Middlesex
- Agency: Stanek Lemon Crouse & Meeks, PA
- International Application: PCT/IB2018/057726 WO 20181004
- International Announcement: WO2019/069270 WO 20190411
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D401/14 ; C07D405/14
Abstract:
Disclosed are compounds having the formula: (I) wherein q, r, s, A, B, C, RA1, RA2, RB1, RB2, RC1, RC2, R3, R4, R5, R6, R14, R15, R16, R17, Rx, and Ry are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.
Public/Granted literature
- US20200291001A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Public/Granted day:2020-09-17
Information query
